May 7, 2021

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge. In the long run, the waiver proposal undermines the existing vaccine eco-system built in the crisis urgency.
May 4, 2021

Interview with… Juan Medina, Co-Founder & CEO at Kaffe Bueno

EuropaBio sat down with new corporate member Kaffe Bueno, to find out more about the future of coffee.
May 4, 2021

Kaffe Bueno joins EuropaBio: unlocking coffee’s therapeutic and industrial potential

EuropaBio is delighted to announce that Kaffe Bueno joined the association as a corporate member.
April 28, 2021

Interview with… Agne Vaitkeviciene, Executive Director of LBTA

EuropaBio sat down with new National Association Member from Lithuania.
April 21, 2021

Interview with… Kristina Eskenazi, Chair of Health & Life Sciences Cluster Bulgaria

EuropaBio sat down with new National Association Member from Bulgaria, to find out their plans for their national activities within an international framework.
April 14, 2021

Interview with… Dr. Kim Domela Kjøller, CEO at UNION Therapeutics

EuropaBio sat down with new Member UNION Therapeutics, to find out about its novel anti-infective programme and how it can support Covid treatment in vulnerable patients.
April 14, 2021

UNION Therapeutics joins EuropaBio: building a pipeline for inflammation and infectious diseases

EuropaBio is delighted to announce that UNION Therapeutics has joined the association as a corporate member.
April 6, 2021

Interview with… Dr. Jim Lalonde, Head of Microbial Business Area at INSCRIPTA

EuropaBio sat down with new Member Inscripta, to find out what gets them fired up with their ground breaking ‘benchtop biofoundry’ Onyx™.
April 6, 2021

Inscripta joins EuropaBio: delivering global biotechnology advances

EuropaBio is delighted to announce that Inscripta has joined EuropaBio as an associate member.
March 31, 2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
March 29, 2021

Abolis joins the EuropaBio 25th Anniversary in 2021

EuropaBio is delighted to announce that Abolis has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor.
March 25, 2021

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key.
March 22, 2021

EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe
March 15, 2021

Abolis joins EuropaBio: Sustainable Bio-Based Products

Abolis joins EuropaBio: Sustainable Bio-Based Products.
March 9, 2021

Catalent joins the EuropaBio 25th Anniversary in 2021

EuropaBio is delighted to announce that Catalent has joined EuropaBio’s 25th Anniversary Celebration Programme as a major sponsor.
Become a member